Objective:
To evaluate the clinical value of
clinical pharmacists in clinical
treatment team through participating in the
treatment of one case of
MRSA infection.
Methods:
According to the
infection site,
MRSA infection treatment principle and the characteristics of
drug treatment,
clinical pharmacists assisted
physicians in optimizing the
therapy plan and provided the
pharmaceutical care.
Results:
Physicians adopted the
clinical pharmacist's
suggestions, and the symptoms of
patient were improved with effectively reduced ADR.
Conclusion:
The participation of
clinical pharmacists in the
optimization of anti-infective
therapy plan can improve
efficacy and security.